Business Wire

Limb Lengthening Expert Dr. Dror Paley Opens First Clinic in Middle East at UAE’s Burjeel Medical City

Share

As part of its ongoing efforts to focus on complex care and pediatric sub-specialties, Burjeel Holdings, one of the leading private healthcare services providers in the MENA region,in collaboration with renowned orthopedic surgeon Dr. Dror Paley, has launched a clinic in the UAE. The Paley Middle East Clinic, located at Burjeel Medical City (BMC) in Abu Dhabi, aims to become a hub for complex procedures in the region by providing world-class specialized orthopedic care. It is the first clinic in the Middle East and Asia by Dr. Paley, who has performed around 20,000 limb-lengthening and reconstruction-related procedures.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230110005563/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Dr. Dror Paley and his team at Paley Middle East Clinic in Burjeel Medical City with Dr. Shamsheer-Vayalil, Founder and Chairman, Burjeel Holdings, and other senior management officials. (Photo: AETOSWire)

Dr. Paley is internationally recognized for his expertise in limb lengthening, deformity reconstruction, and joint preservation of children and adults. The clinic at BMC offers diagnosis and treatment of special orthopedic conditions, including congenital limb deformities, post-traumatic limb conditions, bone healing problems, bone defects, skeletal dysplasia, metabolic disorders, foot deformities, and peripheral nerve disorders.

BMC, one of the leading quaternary care facilities in the UAE, expects the clinic, supported by a comprehensive rehabilitation department, to serve as a beacon for orthopedic surgical excellence and innovation.

“I am delighted to start my innings in the UAE with BMC. Together we aim to transform the UAE into a hub for limb lengthening and deformity correction, attracting patients from across the globe for cutting-edge treatments,” said Dr. Paley.

Welcoming Dr. Paley, Mr. John Sunil, CEO, Burjeel Holdings, said, “The collaboration is yet another important step in the Group’s pursuit of delivering healthcare excellence and improving patient outcomes. We are constantly investing in and establishing new partnerships to identify cutting-edge medical technologies and innovations that can help us deliver complex care to the people. Dr. Paley’s expertise will help the people avail of almost every aspect of orthopedic and neurosurgical care, making the UAE a sought-after hub for such services.”

About Burjeel Medical City

Burjeel Medical City is a 400-bed multi-specialty hospital and quaternary care center located in Abu Dhabi, UAE. It offers high-quality specialized treatment and complex care in over 40 adult and pediatric specialties, aided by state-of-the-art medical technology and an international team of experts.

Find more information at https://www.burjeelmedicalcity.com/

*Source: AETOSWire

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

M. Unnikrishnan
krish@burjeelholdings.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Smiths Detection deploys multi-site central image processing solution for DHL Express Australia31.1.2023 00:00:00 CET | Press release

Smiths Detection, a global leader in threat detection and security screening technologies, today announces that it has deployed a fully operational multi-site central image processing and management solution for DHL Express Australia. The solution connects existing Smiths Detection HI-SCAN 10080 EDX-2is high-speed automatic explosive detection scanners at the sites in Sydney, Melbourne and Brisbane into one intelligent network that allows all X-ray images to be analysed at a single central location and provides consolidated data analytics and insights. The intelligent centralised screening solution will enable DHL Express Australia to optimise staffing rostering, as well as significantly increase the utilisation of its security operators while reducing overall operational expenditure. The technology will be used for the safe and efficient screening of international air freight, in line with both TSA and Australian regulations. Ajay Sankaran, Managing Director of Australia & Sales Direc

Valbiotis Announces Positive Results in the Bioavailability and Mode of Action TOTUM•854 Clinical Study, Against High Blood Pressure30.1.2023 17:40:00 CET | Press release

Regulatory News: Valbiotis (FR0013254851 – ALVAL, PEA / SME eligible) (Paris:ALVAL), a commercially oriented Research and Development company, with a commercial purpose, committed to scientific innovation for preventing and combating metabolic and cardiovascular diseases, announces positive results in the bioavailability and mode of action clinical study conducted on TOTUM•854 against high blood pressure, the number one cardiovascular risk factor worldwide. The mode of action results demonstrate a protective effect of TOTUM•854 on vascular wall cells and a reduction in angiotensin I-converting enzyme (ACE1) activity in humans. These robust data confirm the potential of TOTUM•854 to reduce blood pressure at the earliest stages of arterial hypertension, which affect 123 million people in the US and Europe1. They hold great promise for the late-stage clinical development of TOTUM•854. Pascal SIRVENT, Director of Discovery and Preclinical and Translational Research, member of the Executive

Boomi Named a Leader for Ninth Consecutive Time in Gartner® Magic Quadrant™ for Integration Platform as a Service, Worldwide30.1.2023 17:28:00 CET | Press release

BoomiTM, the intelligent connectivity and automation leader, today announced that Gartner has positioned Boomi as a Leader in its Magic Quadrant for Integration Platform as a Service (iPaaS), Worldwide for the ninth consecutive time. Gartner evaluated 16 iPaaS providers on their ability to execute and completeness of vision. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230130005154/en/ Boomi Named a Leader for Ninth Consecutive Time in Gartner® Magic Quadrant™ for Integration Platform as a Service, Worldwide (Graphic: Business Wire) The iPaaS market is projected to reach $11 billion in revenue by 2026.1 Given the advanced capabilities and immense scale of iPaaS vendors, [iPaaS] has become the strategic integration platform of choice for hundreds of thousands of organizations around the world. In many cases, iPaaS has replaced previous generations of integration platform software such as application integration suites, data

Aspen Appoints Mike Duffy To U.K. Boards30.1.2023 16:16:00 CET | Press release

Aspen Insurance Holdings Limited (“Aspen”) is pleased to announce that Mike Duffy has been appointed to the Aspen Managing Agency Limited (“AMAL”) and Aspen Insurance UK Limited (“AIUK”) Boards as a Non-Executive Director, effective February 1, 2023. Mike will join the AMAL and AIUK (together, “Aspen U.K.”) Boards as Senior Independent Non-Executive Director (“SID”), Chair of the Nominations Committee, and Chair of the Governance Committee, subject to regulatory approval. Mike is a vastly experienced and highly respected leader in the Lloyd’s market with a 40-year career across underwriting and broking. He was most recently Group Chief Underwriting Officer for Canopius, where he held several Board roles across the Canopius corporate group of entities. In addition, he has held numerous leadership positions across a range of broking and insurance groups. During his extensive career, Mike has gained significant risk, governance, transaction and regulatory experience across the U.K., U.S.,

Planview Continues Acceleration with Record Revenue in FY’2230.1.2023 15:00:00 CET | Press release

Planview, the leading platform for connected work from portfolio planning to delivery, today announced record annual recurring revenue (ARR) for fiscal year 2022, continuing a trend of strong performance. Planview exceeded $380 million in total ARR for 2022, representing 17% growth year-over-year (YoY). “It was another record year for Planview, underpinned by our commitment to build the digital future of connected work through product innovation and customer success,” said Razat Gaurav, Chief Executive Officer, Planview. “The macroeconomic uncertainties and headwinds faced by organizations today make prioritizing product and project initiatives, and thoughtfully allocating constrained resources and capital, more important than ever. Our global customer base relies on our solutions to help them achieve productivity, efficiency, and positive business outcomes from transformation initiatives across the enterprise.” Fiscal Year-End Highlights Planview achieved record levels for the full fi